Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study

Neurological Sciences

Volumn 35, Issue 7, 2014, Pages 1067-1073

  Syngle, Ashit ^a,b   Verma, Inderjeet ^c   Krishan, Pawan ^c   Garg, Nidhi ^c   Syngle, Vijaita ^a  

^a Healing Touch City Clinic   (India)

^b Fortis Multi Specialty Hospital   (India)

^c PUNJABI UNIVERSITY   (India)

Author keywords

Cardiovascular autonomic neuropathy; Diabetic neuropathy; Leeds assessment of neuropathic symptoms and signs; Minocycline; Sudoscan; Vibration perception threshold

Indexed keywords

MINOCYCLINE; PLACEBO; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; BECK DEPRESSION INVENTORY; CARDIOVASCULAR REFLEX; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEART RATE; HUMAN; LEEDS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGNS; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN DISABILITY INDEX; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIBRATION SENSE; VISUAL ANALOG SCALE; VOMITING; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD; COMPLICATION; DISABILITY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; PILOT STUDY; PROSPECTIVE STUDY; QUESTIONNAIRE;

AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 2; DISABILITY EVALUATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; MULTIVARIATE ANALYSIS; PERIPHERAL NERVOUS SYSTEM DISEASES; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; VISUAL ANALOG SCALE;

EID: 84903376467     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1647-2     Document Type: Article

References (38)

1. Vinik AI, Mehrabyan A (2004) Diabetic neuropathies. Med Clin N Am 88:947-999 (Pubitemid 39090347)
2. Boulton AJ, Freeman R, Vinik AI (2005) Diabetic neuropathies: a statement by the American diabetes association. Diabetes Care 28:956-962 (Pubitemid 40434506)
3. Obrosova IG (2003) Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep 3:439-445
4. Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy (Technical review). Diabetes Care 26:1553-1579 (Pubitemid 36934465)
5. Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
6. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
7. Bhatt LK, Veeranjaneyulu A (2010) Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy. Neurol Sci 31:705-716
8. Cukras CA, Petrou P, Chew EY, Meyerle CB, Wong WT (2012) Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study. Invest Ophthalmol Vis Sci 53:3865-3874
9. http://www.clinicaltrials.gov/show/NCT01779089
10. Siller SS and Broadie K (20120 Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome. Neural Plast 2012. doi: 10.1155/2012/124548
11. Bernardino AL, Kaushal D, Philipp MT (2009) The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis 199:1379-1388
12. Williams G, Gill JS, Aber V, Mather HM (1988) Variability in vibration perception threshold among sites: a potential source of error in biothesiometer. Br Med J 296:233-235 (Pubitemid 18034705)
13. Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and sign. Pain 92:147-157
14. Pollard CA (1984) Preliminary validity study of the Pain Disability Index. Percept Mot Skills 59:974
15. Beck AT, Ward Ch, Mendelson M, Erbaugh Mock J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
16. Ewing DJ, Clarke BF (1986) Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab 15:855-888
17. Mayaudon H, Po Miloche, Bauduceau B (2010) A new method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 36:450-454
18. Zilliox L, Peltier AC, Wren PA, Anderson A, Smith AG, Singleton JR, Feldman EL, Alexander NB, Russell JW (2011) Assessing autonomic dysfunction in early diabetic neuropathy: the survey of autonomic symptoms. Neurology 76:1099-1105
19. Kumar A, Malaviya AN, Pandhi A, Singh R (2002) Validation of an Indian version of the Health Assessment Questionnaire in patients with rheumatoid arthritis. Rheumatology 41:1457-1459
20. Kuritzky L, Samraj GP (2008) Current treatments in the management of diabetic peripheral neuropathetic pain. Pain Medicine News special edition
21. Malik RA, Williamson S, Abott C, Carrington AL, Iqbal J, Schady W, Boulton AJ (1998) Effect of angiotensin-converting enzyme (ACE) inhibitor trandopril on human diabetic neuropathy: randomized double blind controlled trial. Lancet 352:1978-1981
22. Obrosova IG, Van Huysen C, Fathallah L, Cao XC, Greene DA, Stevens MJ (2002) An aldose reductase inhibitor reverses early diabetesinduced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 16:123-125
23. Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, Tritschler HJ, Mehnert H (1999) Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a 2 year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha lipoic acid in diabetic neuropathy. Free Radic Res 31:171-179 (Pubitemid 29435878)
24. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G (1997) Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care 20:369-373 (Pubitemid 27098226)
25. Manzella D, Barbieri M, Ragno E, Paolisso G (2001) Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr 73:1052-1057 (Pubitemid 32496944)
26. Massova I, Kotra LP, Fridman R, Mobashery S (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 12:1075-1095 (Pubitemid 28418938)
27. Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, Ji RR (2008) Distinct roles of matrix metalloproteases in the early and late phase development of neuropathic pain. Nat Med 14:331-336 (Pubitemid 351347915)
28. Ji RR, Xu ZZ, Wang X, Lo EH (2009) Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci 30:336-340
29. Vinik AI, Erbas T, Casellini CM (2013) Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig 4:4-18
30. Yrjänheikki J, Tikka T, Keinänen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500
31. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771 (Pubitemid 35386294)
32. Choi Y, Kim HS, Shin KY et al (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32:2393- 2404
33. Nikodemova M, Ducan ID, Watters JJ (2006) Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem 96:314-323
34. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318
35. Gonzalez-Scarano F, Baltuch G (1999) Microglia as mediators of inflammatory and degenerative disease. Annu Rev Neurosci 22:219-240 (Pubitemid 29144887)
36. Lewandowski KC, Banach E, Bieńkiewicz M, Lewiński A (2011) Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia. Arch Med Sci 7:294-303
37. Jambart S, Ammache Z, Haddad F, Younes A, Hassoun A, Abdalla K, Selwan CA, Sunna N, Wajsbrot D, Youseif E (2011) Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the Middle East region. J Int Med Res 39:366-377
38. Kullberg CE, Arnqvist HJ (1996) Impaired vibration perception threshold and long-term mean HbA1c in patients with type 1 diabetes mellitus. Diabet Med 13:1027-1032 (Pubitemid 26420062)